Generic substitution - Is it safe in patients at high cardiovascular risk?

South African Medical Journal

Volumn 92, Issue 8 I, 2002, Pages 603-604

  Rayner, Brain ^a   Buchanan Lee, Biddy ^a   Brink, Johan ^a   Opie, Lionel ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADALAT XL; ALLOPURINOL; AMLODIPINE; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; FUROSEMIDE; GENERIC DRUG; HYDROCHLOROTHIAZIDE; INOTROPIC AGENT; NIFEDIPINE; PERINDOPRIL; PRAZOSIN; SPIRONOLACTONE; VASCARD;

ADULT; AGED; BRADYCARDIA; BREATHING DISORDER; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CODING; COLLAPSE; CONTROLLED STUDY; DRUG FATALITY; DRUG INFORMATION; DRUG SAFETY; FEMALE; HEADACHE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; MALE; NOTE; PHARMACY AND THERAPEUTICS COMMITTEE; SENSORY DYSFUNCTION; STROKE; SUSTAINED RELEASE FORMULATION; THORAX PAIN; TONIC CLONIC SEIZURE; TRANSIENT ISCHEMIC ATTACK;

AGED; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; DRUGS, GENERIC; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; RISK FACTORS; THERAPEUTIC EQUIVALENCY;

EID: 0036686533     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (4)

1. The risk of myocardial infarction associated with antihypertensive therapies
2. Long-term survival and use of antihypertensive medications in older persons
3. Morbidity and mortality in patients randomised to double-blind treatment with long-acting calcium channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
4. Effects of ACE inhibitors calcium channel blockers and other blood pressure-lowering drugs: Results of prospectively designed overviews of randomised trials